Inventor · disambiguated record
Pontus Forsell
Also filed as: FORSELL PONTUS
2 granted patents·4 pending applications·2 citations·filing 2017–2024
40Inventor score
Files withAlzeCure Pharma AB6
Top patents by PatentIndex Score
6 records- 0183US12209071B2Triazine derivatives for treating diseases relating to neurotrophinsAlzeCure Pharma AB·Filed 2022·Granted Jan 28, 2025·1 cites·32 claims
- 0274US2025214948A1Triazine derivatives for treating diseases relating to neurotrophinsAlzeCure Pharma AB·Filed 2024·Application pending·0 cites
- 0368US11840524B24-substituted phenyl-1,3,5-triazine derivatives as modulators of TrK receptorsAlzeCure Pharma AB·Filed 2019·Granted Dec 12, 2023·1 cites·33 claims
- 0443US2022324819A1Triazine derivatives for treating diseases relating to neurotrophinsAlzeCure Pharma AB·Filed 2020·Application pending·0 cites
- 0537US2020113910A1Triazinetrione derivatives and their use as modulators of neurotrophin receptor and receptor tyrosine kinasesAlzeCure Pharma AB·Filed 2017·Application pending·0 cites
- 0637US2021261513A14-substituted phenyl-1,3,5-triazine derivatives as modulators of trk receptorsAlzeCure Pharma AB·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Pontus Forsell files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →